TG Therapeutics, Inc. (TGTX) is up 20.41 percent, gaining $6.05 to trade at $36.14during Monday's trading after reporting fourth-quarter revenue of $108.2 million, a significant increase from $44.0 million a year ago.
The stock opened at $30.40 and has traded between $30.28 and $35.96 today. Volume has reached 6.4 million shares, well above the average of 2.1 million. TG Therapeutics' 52-week range is $12.93 to $36.84.
The company posted net income of $23.3 million, compared to a net loss of $14.4 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.